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Abstract
 Aim: The objective of this study is to assess the accuracy of 
the diagnosis and appropriateness of antipsychotic medication 
prescribed to children and adolescents referred to child 
guidance clinic, and how many of these remained on the said 
medication after consultant psychiatrist and multidisciplinary 
team review.
Method: A retrospective case notes review of all the 
children referred to a child guidance clinic in the period June 
2005 to July 2006 were analysed, looking specifically at the 
referral tickets, the treatment on first interview with a member 
of the multidisciplinary team at the clinic, the working diagnosis 
of the team, and the management plan after at least six months 
of follow up at child guidance clinic. There was very good inter-
rater reliability between the two observers looking at the case 
notes.
Results:  One hundred and fifty four (63.1%) out of a total of 
244 children who were referred carried an admission diagnosis, 
which differed from the working diagnosis after 6 months. 
A total of 66 children (27%) were started on various types of 
psychiatric treatment prior to referral. Thirty (45.5%) of these 
were prescribed sulpiride, an atypical neuroleptic. Following 
review by the multi-disciplinary team, the medication of 25 
(83.3%) of these children was terminated or altered.     
Conclusion: This report highlights the need of consultation-
liaison with general practitioners and also Continued Medical 
Education courses for general practice management in child 
and adolescent psychiatry. It is advisable that non psychiatric 
specialists limit the use of antipsychotic medication to children 
and adolescents without expert advice and in addition, should 
refer all such children with urgency.
Introduction
The practice of child psychiatry differs from that of adults 
in a number of ways. Children seldom realise they have a 
problem. Their problems may reflect those of the family, the 
child’s stage of development and their lack of ability to express 
themselves. Treatment used in child psychiatry also differs 
from that of adults; oral medication is less used when dealing 
with children. 
General Practitioners (GPs) will frequently be the initial 
source of assistance for patients with acute psychiatric illnesses 
and their families.1 The most common psychiatric complaints 
seen by the GP are for somatic complaints (50% of cases). Other 
reasons include depressive episodes, dysthymia, adjustment 
disorder, anxiety disorder and obsessive-compulsive disorder.2 
It is essential that GPs take medical history, examination, 
investigations and risk assessment before referring patients. The 
referral should be specific.3 Approximately 70% of depression 
disorders in children were not diagnosed during consultation 
with GPs.2 
 Studies reveal that antipsychotic medications are being 
commonly and extensively prescribed to children and 
adolescents, despite the relative limited scientific evidence to 
support their paediatric use.4 
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  The most convincing evidence of the efficacy of the atypical 
neuroleptics in children and adolescents is in the treatment of 
schizophrenia, and pervasive developmental disorders. Other 
efficacious uses of atypical neuroleptics have been reported in 
the treatment of tic disorders (including Tourette’s syndrome) 
and bipolar disorders.5 The most frequently prescribed atypical 
agents are risperdone, quetiapine and aripiprazole in children 
with the most common age group being above 9 years of 
age.4 Risperdone is an atypical antipsychotic that is generally 
well tolerated and numerous studies have been published 
investigating this drug in children.6 A study on Sulpiride reported 
that due to its action on the dopaminergic, serotoninergic and 
opiatergic neurotransmitter systems it clearly reduces self-
injurious behaviour in autistic children.7
The aim of this study was to assess the accuracy of the 
diagnosis for which children and adolescents were referred to 
the Child Guidance Clinic by non psychiatric specialists over a 
period of one year. Also to assess the reason for non psychiatric 
specialists to prescribe antipsychotic medication in this age 
group.
 
Methodology
All the children referred to Child Guidance Clinic (CGC) 
at St Luke’s Hospital (SLH), Malta, between the period June 
2005 and July 2006 were included in this retrospective cross-
sectional analysis. The total sample included 244 children aged 
between 2 and 16 years. The inclusion criteria, for this study 
makes the sample truly representative of the child guidance 
clinic population, thus reducing any selection bias. No exclusion 
criteria were used in this study. 
Analysis included reviewing medical records of all 
children and adolescents referred within that year together 
with the referring agent (GPs, paediatricians and consultant 
psychiatrists). Each of the case notes was reviewed by two 
individuals so as to reduce interviewer bias. Good inter-rater 
reliability existed between both observers. Almost all data 
collected by the observers was similar, any differences were 
accounted for by together returning to the case notes and 
correcting the discrepancy. Measures were taken while reviewing 
the case notes to comply with the Data Protection Act. The 
initial reason for referral was compared to the diagnosis made 
by the multi-disciplinary team, this, being later finalised by the 
consultant psychiatrist. Diagnosis was made according to the 
International Classification of mental and behavioural disorders 
(WHO, 1992) using its six axes system.  
The study also assessed the percentage of children previously 
referred on treatment as opposed to those on none. The study 
confines itself to assess the number of children referred on 
antipsychotic treatment, the prescriber and the reason for 
commencing treatment. Emergent results were compared to 
the final diagnosis and management, after a six-month period. 
All changes in diagnosis were listed as misdiagnoses, and all 
changes in treatment were charted. 
Statistical methods
All data was inputted into Microsoft Excel and then analysed 
using an online Fisher’s Exact & Chi-squared test calculator.8 
Descriptive statistics were also compiled in the form of tables.
Results
Two hundred and forty four children met the inclusion 
criteria. One hundred and sixty three were males (66.8%) and 81 
were females (33.1%) with a mean age of 9.3 ± 3.5 years, (ranging 
from 2 to 16 years). The ages were further subdivided into three 
groups. The first group of children (n=38) fell into the 5 years 
and under age bracket. This age group was chosen since most 
diagnoses cannot be made before the age of 5 in child psychiatry; 
also, the earlier the onset of initiating antipsychotic treatment, 
the greater the risks of side effects. In the second age group, 6 to 
10 year olds, 118 children were included.  Eighty eight children 
aged between 11 and 16 formed the last age group.  
Referrals for this study were as follows; the greatest number 
of children (187 in all) was referred by family practitioners; 
48 were referred by paediatricians; and 9 by consultant 
psychiatrists. The reason for referral to Child Guidance Clinic 
can be viewed in Figure 1. 
BPA – behavioural problems and aggression; NPD 
– neurotic and psychosomatic disorders; LD – learning 
difficulties; AD – affective disorders; CD – conduct disorders; 
BED – other disorders of behaviour and emotion; PDD 
– pervasive developmental disorders; SD – sleep disorders; 
TD – tic disorder; EmD – emotional disorders; ED – eating 
disorders; Ass – Assessment.   
It was observed that of a total of 244 children referred to 
CGC, 154 (63.1%) were misdiagnosed by the referring doctor 
when compared to the final diagnosis. The most frequently 
diagnosed mental and behavioural disorders by consultant 
psychiatrists were neurosis and stress related disorders (n=55) 
and of these 81.8 % were misdiagnosed by non psychiatric 
specialists. Of the 46 diagnosed by psychiatrist specialists with 
diverse conduct disorders, 69.6% were misdiagnosed. Forty 
four were diagnosed by psychiatrists with attention deficit and 
hyperactivity disorder, and 47.7% of these were misdiagnosed 
by other referring doctors. Other various psychiatric illnesses 
were observed in the referred children, however in smaller 
percentages.
A total of 66 (27%) children were prescribed various types 
of psychiatric treatment, prior to referral. The main reason for 
being referred to this clinic, in these cases, was failure to respond 
to the previously prescribed medication. As indicated in the 
ticket of referral, a number of these children were tried on more 
than one type of medication before being referred for further 
assessment. Table 1 illustrates the distribution of children 
referred on treatment and how many were discontinued. Of the 
children prescribed with medication the most popular form of 
treatment used was sulpiride (an antipsychotic). This totalled 
30 children (45.5%).
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Figure 1: Reasons for referrals to Child Guidance Clinic
BPA – behavioural problems and aggression; NPD – neurotic and psychosomatic disorders; LD – learning difficulties; 
AD – affective disorders; CD – conduct disorders; BED – other disorders of behaviour and emotion; 
PDD – pervasive developmental disorders; SD – sleep disorders; TD – tic disorder; EmD – emotional disorders; 
ED – eating disorders; Ass – Assessment 
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Since sulpiride was the most commonly prescribed 
medication started by non-psychiatrist specialists, further 
investigations into the reasons for the choice of such medication 
and the outcome of this form of management were considered 
necessary. Of the 30 children who were started on sulpiride, the 
majority were referred by GPs (n=24), paediatricians (n=9), and 
one child by a consultant psychiatrist, (refer to tables 2a and 2b). 
Whether patients were previously referred on sulpiride or not 
did not vary significantly in relation to referral source (p=0.846). 
This subgroup of 30 youngsters constituted 11 females and 19 
males.  No significant difference by gender was noted between 
the two groups (p=0.706).
Table 3 shows in-depth analysis of the reason for starting 
the patient on sulpiride. Investigating children’s improvement 
in their diagnosed mental and behavioural disorders after a 6 
month period, results show that only 5 remained on the same 
medication (sulpiride), as was started prior to referral. 4 children 
were diagnosed by the child psychiatrist as suffering from a form 
of conduct disorder and one child from ADHD. 
The diagnosis of mental illness and behavioural disorders 
of such children, as given at the Child Guidance Clinic outlined 
in Table 3. Follow-up management after six months of the 
25 children who were no longer left on sulpiride indicated in 
Table 4. 
Discussion
In children and adolescents, psychotropic medication should 
be started by a consultant psychiatrist for two main reasons; the 
first being that treatment is started following assessment and 
diagnosis made by a multi disciplinary team. The other reason is 
that the same medication used in general adult psychiatry may 
have a different use in children or may not even be licensed for 
Treatment 
on referral
Treatment 
discontinued
Treatment types n Frequency (%)
Sulpiride 30 25 83.3
OtherAntipsychotics 
(Including Risperdone) 
6 6 100.0
Propranolol 1 1 100.0
Antidepressants
(Including TCAs + SSRI)
15 13 86.7
Antihistaminics 6 6 100.0
Anticonvulsants 5 2 40.0
Anxiolytics 3 3 100.0
Totals   84.8
Table 1: Treatment on referral
use in children.9 The use of atypical antipsychotics by consultant 
psychiatrists should be critically assessed and compared with the 
benefits achieved by psychosocial interventions. It should not 
be resorted to as a first line treatment but used only in resistant 
cases. The pros and cons of using psychiatric medication should 
be well evaluated prior to its commencement.10 In this study the 
reason for four children being left on sulpiride by the psychiatrist 
for conduct disorders, was because they were not responsive to 
other oral medication as well as psychotherapy. Sulpiride was 
prescribed as these patients were of danger to themselves or 
others. Following a risk assessment it was considered of greater 
harm had they not been started on antipsychotic medication. 
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From the above results, according to the referral tickets a 
high percentage of children were misdiagnosed, and if correctly 
diagnosed were started on antipsychotic medication for the 
wrong indications. This situation would improve if consultant-
liaison with the GP would be made accessible. By providing 
advice over the phone in urgent cases, and with GPs, a one-off 
assessment by the psychiatrist could then result in feedback to 
the GP for regular monitoring.11 In Australia consultation liaison 
services were offered by psychiatrists. This resulted in both GPs 
and psychiatrists expressing a high rate of satisfaction with this 
mode of service. GPs also reported an increase in knowledge and 
confidence in dealing with psychiatric patients.11 
Prior to referral a thorough history and examination by 
the GP with a specific reason for referral would facilitate 
prioritisation and insight of the cases seen at CGC. The authors 
of this study also recommend Continued Medical Education 
courses for general practitioners in child and adolescent 
psychiatry as a means of further improving the standard of 
community care offered in this age range. 
 Good quality collaboration between GPs and other 
professionals is essential. Almost all GPs (95%) had positive 
experiences when co-operating with different professionals, but 
only 47% felt that they had good contact with a child psychiatrist. 
This poses a challenge for both primary and secondary care 
Reason why sulpiride 
was started by the non specialist n
Diagnosis given by multi-disciplinary team 
after at least 6 months of follow up n
ADHD 8 ADHD 5
Psychosomatisation disorders 4 Somatoform disorders 3
Conduct disorders 9 Conduct disorders 7
Affective disorder 2 Affective disorders 0
School phobia 2 Separation anxiety 3
Learning difficulties 1 Dev dis. Of Speech and language 1
Autism 1 Pervasive dev. Disorders (autism) 2
Tics 1 Tic disorders 1
Neurotic and stress related disorder 1 Neurosis and stress related disorders 6
Blank 1 Under evaluation 2
Total 0 Total 0
Table 3: The sulpiride group: reason for referral and final diagnosis at CGC
Age 2-5 yrs % 6-10 yrs % 11-16 yrs % n %
Sulpiride 5 19.2 14 53.8 7 26.9 2 100
Other Rx or Nil 30 18.6 69 42.9 62 38.5  100
Totals   9 
Age 2-5 yrs % 6-10 yrs % 11-16 yrs % n %
Sulpiride 0 0 2 40 3 60  100
Other Rx or Nil 8 18.6 21 48.8 14 32.6  100
Totals  2  
Table 2b: Referred by Paediatricians (p= 0.3761)
Table 2a: Referred by GPs (p= 0.4802)
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level doctors.12 The GPs’ attitudes toward psychotic disorders 
and their treatment in the primary health care system resulted 
in only 27% of GPs seeking structured and advanced education 
about psychiatry.13
Atypical antipsychotic medication was prescribed as 
treatment for children prior to admission to CGC. In all cases but 
one, the antipsychotic started by the consultant psychiatrist was 
the newer atypical antipsychotic risperidone. Interestingly in all 
referrals from non-psychiatrists the antipsychotic prescribed 
was sulpiride. Sulpiride is a selective dopamine D2 antagonist 
with antipsychotic and antidepressant activity. 
 As reviewed in the results, sulpiride was started for the 
wrong reason in most cases and therefore the children made 
little or no clinical improvement. 
The misuse of sulpiride by the primary level care doctors 
is of concern considering that this is an antipsychotic with a 
number of long term and short-term side effects. The use of 
sulpiride is not indicated in children under 14 years of age.14 
Pooled data obtained from published studies emphasise 
hyperprolactinaemia as being one of the disturbing side effects.15 
Few studies report the adverse effects of prolonged prolactin 
elevation in children, including: stunted growth, delayed sexual 
development16 galactorrhoea17, gynaecomastia, weight gain and 
osteoporosis.18 One particular study reported a ten-fold increase 
in serum prolactin levels above the baseline level after one 
month of treatment.
Patients reported tardive motor and phonic tics induced by 
sulpiride following prolonged treatment19. The development of 
tardive dyskinesia following long-term treatment with sulpiride 
has been reported.20 In controlled studies the incidence of 
extrapyramidal effects has been as high as 30%. 
Liver and renal function tests should be performed every six 
months to a year in patients on sulpiride, including a physical 
examination looking out for signs and symptoms of extra 
pyramidal symptoms, which the patients should be informed 
about prior to commencement of treatment. 
Limitations and strengths of study
    Some of the limitations in this study include; data 
being collected retrospectively and that it was solely collected 
from medical files without actually interviewing the children. 
Consequently, all information is based on written data; hence, 
there is no detail available about the duration of sulpiride 
treatment to the child. No contact with the referring GP was made 
to acquire any missing data. The study suffers from a Berkson’s 
bias in that the sample population is truly representative of the 
patients who attended CGC but not of the target population as 
a whole. Due a lack of resources the observers carrying out this 
study were not blinded, thus emerges an observer bias in the 
data collection and write up of results.
The strengths of this study include; all case notes of children 
referred in the specified time frame were included in the study 
and this study is independent from pharmaceutical industry 
sponsorship. 
Emergent results put forward an issue that should act as an 
eye-opener for the targeted audience; that regarding the number 
of unrecorded children on sulpiride within the community. In 
the light of such a concern, an immediate need for consultation 
- liaison with general practitioners and also continued medical 
education courses for general practice management in children 
and adolescent psychiatry is highly recommended. A well 
structured and tightly knit professional relationship between 
consultant psychiatrist and non psychiatric specialists would 
help to facilitate urgent referrals to the Child Guidance Clinic. 
Regular letters of correspondence with details of the assessment 
and management plan would increase collaboration between 
both sides; as a result the standard of clinical care for children 
and adolescents should improve.
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